References
AD
VASODILATION
Research protocol design.Clinical and biochemical characteristics of the participants at baseline and post-treatment.Data are presented as median (interquartile range—IQR). *: Comparison of intra-groups post–pre-tests. **: Comparison between groups at baseline. Significant values are bold.Comparison of the median differences (post-test—pre-test; ∆) between groups.Data are presented as median (interquartile range—IQR). Significant values are bold.Partial correlations between vascular reactivity parameters, noradrenaline, and Sirtuin 1 adjusted by treatment group and sex.Values are detailed as correlation coefficient (r). AD: artery diameter; FMD: flow-mediated vasodilation; NA: noradrenaline; NMD: nitrate-mediated vasodilation; *: Effects of Sirtuin 1 on flow-mediated vasodilation stratified by sex and intervention.The first model included all variables (i.e., triglycerides, BMI, total cholesterol, noradrenaline, circulating, and expression of Sirtuin 1). Excluded variables in the final model are indicated by “n/a”. Significant values are bold.Effects of Sirtuin 1 on nitrate-mediated vasodilation stratified by sex and intervention.The first model included all variables (i.e., triglycerides, BMI, total cholesterol, noradrenaline, circulating, and expression of Sirtuin 1). Excluded variables in the final model are indicated by “n/a”. Significant values are bold.